| dbo:abstract
|
- Debra Auguste is an American chemical engineer and professor at Northeastern University in the Department of Chemical Engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering. (en)
|
| dbo:almaMater
| |
| dbo:award
| |
| dbo:institution
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 23215 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:awards
|
- 50 (xsd:integer)
- Elected Fellow of the American Institute for Medical and Biological Engineering (en)
- Presidential Early Career Award for Scientists and Engineers in the United States Department of Health and Human Services (en)
- National Institutes of Health Director’s New Innovator Award (en)
|
| dbp:caption
|
- Auguste upon receiving the PECASE for 2012 (en)
|
| dbp:fields
|
- Chemical engineering, biomedical engineering (en)
|
| dbp:knownFor
|
- Biocompatible liposome drug delivery design (en)
|
| dbp:name
| |
| dbp:nationality
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Debra Auguste is an American chemical engineer and professor at Northeastern University in the Department of Chemical Engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
